Press & News
People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
At 2cureX, we’re pioneers of 3D microtumors in cancer therapy, focused on improving the outcomes of cancer treatment
Read
Product launch
2cureX launches IndiTreat® for metastasised colon cancer, the world’s first CE validated IVD based on microtumors
Read more
Nov 26
News
2cureX launches new website
Nov 11
2cureX presents commercial roadmap 2021 – 2023
Nov 2
The commercialization of IndiTreat® has taken off
Oct 12
2cureX featured in Dansk Biotek’s overview of Danish biotech
Sep 28
2cureX Newsletter ESMO 2020 virtual conference
Sep 19
2cureX launches IndiTreat (BioStock)
Sep 16
New Danish cancer-test reaches market (Indblik.dk)
Sep 8
Pre-launch activities for 2cureX pay off (BioStock)
Get notified on mail, when news or press release is posted on our website
